(Q39265439)

10 September 2017

Site-specific modification of adeno-associated viruses via a genetically engineered aldehyde tag. (English)

1 reference

10 September 2017

Yarong Liu

1

1 reference

10 September 2017

Yun Fang

2

1 reference

10 September 2017

Yu Zhou

3

1 reference

10 September 2017

Ebrahim Zandi

4

1 reference

10 September 2017

Chi-Lin Lee

5

1 reference

10 September 2017

Kye-Il Joo

6

1 reference

10 September 2017

Pin Wang

7

1 reference

10 September 2017

5 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

9

1 reference

10 September 2017

3

1 reference

10 September 2017

421-429

1 reference

Engineering targeted viral vectors for gene therapy

10 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Gene therapy clinical trials worldwide 1989-2004-an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Unnatural amino acid incorporation into virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Genome-free viral capsids as multivalent carriers for taxol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Clinical gene therapy using recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

AAV hybrid serotypes: improved vectors for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Adeno-associated virus serotypes: vector toolkit for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Recombinant adeno-associated virus for muscle directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Prospects for the use of adeno-associated virus as a vector for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Effect of gene therapy on visual function in Leber's congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Deleterious effect of peptide insertions in a permissive site of the AAV2 capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Introducing genetically encoded aldehydes into proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Glycerol facilitates the disaggregation of recombinant adeno-associated virus serotype 2 on mica surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Differential Requirements of Rab5 and Rab7 for Endocytosis of Influenza and Other Enveloped Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Visualization of targeted transduction by engineered lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Recycling of the human prostacyclin receptor is regulated through a direct interaction with Rab11a GTPase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Intracellular trafficking of adeno-associated viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

Quantification of adeno-associated virus particles and empty capsids by optical density measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201201661

21 January 2018

Identifiers

DOI

10.1002/SMLL.201201661

1 reference

release_v2ecasonpbfabaykhx6yiexasi

10 September 2017

0 references

1 reference